Showing promise in the arena of excess body fat treatment, retatrutide is a distinct strategy. Unlike many current medications, retatrutide functions as a double agonist, simultaneously affecting both glucagon-like peptide-1 (GLP-1) and glucose-responsive insulinotropic hormone (GIP) sensors. This simultaneous engagement encourages multiple advanta… Read More